Evidence map›Paper›PMID 34402499›Full record

ArticleThe Biochemical journal2021

Insight into the function of active site residues in the catalytic mechanism of human ferrochelatase.

Amy E Medlock, Wided Najahi-Missaoui, Mesafint T Shiferaw, Angela N Albetel, William N Lanzilotta, Harry A Dailey

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Regulation of mitochondrial iron homeostasis in tumor cells.Molecular medicine (Cambridge, Mass.) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Structural aspects of enzymes involved in prokaryotic Gram-positive heme biosynthesis.Computational and structural biotechnology journal · 2023
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amy E MedlockDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, U.S.A.ORCID 0000-0001-9402-3593
Wided Najahi-MissaouiDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, U.S.A.
Mesafint T ShiferawDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, U.S.A.
Angela N AlbetelDepartment of Chemistry, University of Georgia, Athens, GA 30602, U.S.A.
William N LanzilottaDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, U.S.A.
Harry A DaileyDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, U.S.A.
University of Georgia · US

Funding

Erythroid heme synthesis regulation via the ferrochelatase [2Fe-2S] clusterR01DK096051 · NIDDK · UNIVERSITY OF GEORGIA · PI DAILEY, HARRY A · 2012 to 2015
$1.5M
A radical new paradigm for heme degradation in enteric pathogensR01GM124203 · NIGMS · UNIVERSITY OF GEORGIA · PI LANZILOTTA, WILLIAM N · 2017 to 2020
$1.3M
Identifying the Function of the Mitochondrial Heme Biosynthesis Complex in ErythropoiesisR01DK111653 · NIDDK · UNIVERSITY OF GEORGIA · PI MEDLOCK, AMY ELIZABETH · 2017 to 2018
$450k
NIDDK NIH HHS L30 DK096501NIDDK NIH HHS R01 DK096051NIDDK NIH HHS R01 DK111653NIGMS NIH HHS R01 GM124203
6 · The paper itself

Abstract

Ferrochelatase catalyzes the insertion of ferrous iron into a porphyrin macrocycle to produce the essential cofactor, heme. In humans this enzyme not only catalyzes the terminal step, but also serves a regulatory step in the heme synthesis pathway. Over a dozen crystal structures of human ferrochelatase have been solved and many variants have been characterized kinetically. In addition, hydrogen deuterium exchange, resonance Raman, molecular dynamics, and high level quantum mechanic studies have added to our understanding of the catalytic cycle of the enzyme. However, an understanding of how the metal ion is delivered and the specific role that active site residues play in catalysis remain open questions. Data are consistent with metal binding and insertion occurring from the side opposite from where pyrrole proton abstraction takes place. To better understand iron delivery and binding as well as the role of conserved residues in the active site, we have constructed and characterized a series of enzyme variants. Crystallographic studies as well as rescue and kinetic analysis of variants were performed. Data from these studies are consistent with the M76 residue playing a role in active site metal binding and formation of a weak iron protein ligand being necessary for product release. Additionally, structural data support a role for E343 in proton abstraction and product release in coordination with a peptide loop composed of Q302, S303 and K304 that act a metal sensor.

Indexed as

Models, MolecularBiocatalysisCatalytic DomainCrystallizationFerrochelataseHemeHistidineHumansIronKineticsLigandsProtein BindingProtonsProtoporphyrinsFECH protein, humanFerrochelataseHemeHistidineIronLigandsProtonsProtoporphyrinsferrochelatasehemeheme synthesisiron

Identifiers

PMID34402499
PMCPMC9138182
OpenAlexW3195932523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.